Molecular-Guided Therapy for Childhood Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 56
Summary
- Conditions
- Ependymoma
- Choroid Plexus Neoplasms
- Clear Cell Sarcoma
- Craniopharyngioma
- Rhabdomyosarcoma
- Neuroblastoma
- Dysembryoplastic Neuroepithelial Tumor
- Osteosarcoma
- Primitive Neuroectodermal Tumors (PNETs)
- Ewing's Sarcoma
- Germ Cell Tumors
- Glioma
- Liver Tumors
- Meningioma
- Wilm's Tumor
- Non-rhabdomyosarcoma
- Malignant Rhabdoid Tumor
- Renal Cell Carcinoma
- Medulloblastoma
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 1321 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02162732
- Collaborators
- Translational Genomics Research Institute
- Dell, Inc.
- Investigators
- Study Chair: Giselle Sholler, MD Beat Childhood Cancer at Atrium Health
Get Well Soon